Correlation between inflammatory biomarkers in biological fluids in patients with ovarian endometriosis

Abstract

BACKGROUND: To date, there are no available screening techniques allowing to distinguish groups of women with the risk of endometriosis. Therefore, many researchers are searching for meaningful biomarkers for non-invasive diagnosis. The peritoneal fluid is subject to multidirectional changes in patients with external genital endometriosis, although its sampling requires invasive procedure. Testing of the inflammatory markers in saliva is a simple and safe method of particular interest, given that its sampling is non-invasive.

AIM: To assess the correlations between the level of inflammatory biomarkers in the peritoneal fluid and saliva in patients with ovarian endometriosis.

MATERIAL AND METHODS: A prospective cohort comparative study of 46 women with ovarian endometriosis was carried out. Inclusion criteria: confirmed diagnosis of ovarian endometriosis; age between 18 and 40 years; written informed consent for surgical intervention and for participation in the study; no prior hormonal treatment. Non-inclusion criteria: patient's refusal to participate in the study; age below 18 and above 40 years; contraindications for surgical treatment; oral inflammatory diseases. Patients were excluded if the diagnosis could not be visually confirmed during surgery or if there were histological discrepancies. All patients underwent laparoscopic cystectomy. Peritoneal fluid samples were collected during surgery. Mixed unstimulated saliva was collected before surgery in the morning, on an empty stomach. The levels of interleukins and of vascular endothelial growth factor were assessed in biological fluids.

RESULTS: The mean age of the study subjects was 32,4±6,1 years. Correlation analysis showed a direct statistically significant moderate relationship between the levels of IL-6 (r=0.548; p=0.001) and IL-8 (r=0.360; p=0.026) in the peritoneal fluid and saliva, respectively.

CONCLUSION: These data suggest that the onset and progression of endometriosis are associated with the increase of inflammatory cytokine levels both in the peritoneal fluid and in saliva. This may serve a potential tool for diagnosis and assessment of the severity of endometriosis. Evaluation of IL-6 and IL-8 levels in saliva may be useful in clinical practice in patients with external genital endometriosis.

Keywords

endometriosis / endometrioma / interleukins / saliva / biomarker

References

[1] Becker CM, Bokor A, Heikinheimo O, et al. ESHRE guideline: endometriosis. Hum Reprod Open. 2022;2022(2):hoac009. doi: 10.1093/hropen/hoac009

[2] Becker C.M., Bokor A., Heikinheimo O., et al. ESHRE guideline: endometriosis // Hum Reprod Open. 2022. Vol. 2022, N 2. P. hoac009. doi: 10.1093/hropen/hoac009

[3] Becker CM, Bokor A, Heikinheimo O, et al. ESHRE guideline: endometriosis. Hum Reprod Open. 2022;2022(2):hoac009. doi: 10.1093/hropen/hoac009

[4] Adamyan LV, Andreeva EN. Endometriosis and its global impact on a woman’s body. Russian Journal of Human Reproduction. 2022;28(1):54–64. EDN: ELOTDZ doi: 10.17116/repro20222801154

[5] Адамян Л.В., Андреева Е.Н. Эндометриоз и его глобальное влияние на организм женщины // Проблемы репродукции. 2022. Т. 28, № 1. С. 54–64. EDN: ELOTDZ doi: 10.17116/repro20222801154

[6] Adamyan LV, Andreeva EN. Endometriosis and its global impact on a woman’s body. Russian Journal of Human Reproduction. 2022;28(1):54–64. EDN: ELOTDZ doi: 10.17116/repro20222801154

[7] Zondervan KT, Becker CM, Missmer SA. Endometriosis. N Engl J Med. 2020;382(13):1244–1256. doi: 10.1056/NEJMra1810764

[8] Zondervan K.T, Becker C.M, Missmer S.A. Endometriosis // N Engl J Med. 2020. Vol. 382, N 13. P. 1244–1256. doi: 10.1056/NEJMra1810764

[9] Zondervan KT, Becker CM, Missmer SA. Endometriosis. N Engl J Med. 2020;382(13):1244–1256. doi: 10.1056/NEJMra1810764

[10] Sukhikh GT, Serov VN, Adamyan LV, et al. Algorithms for the management of patients with endometriosis: an agreed position of experts from the Russian Society of Obstetricians and Gynecologists. Akusherstvo i Ginekologiya. 2023;(5):159–176. EDN: DTJOZV doi: 10.18565/aig.2023.132

[11] Сухих Г.Т, Серов В.Н., Адамян Л.В., и др. Алгоритмы ведения пациенток с эндометриозом: согласованная позиция экспертов Российского общества акушеров-гинекологов // Акушерство и гинекология. 2023. № 5. С. 159–76. EDN: DTJOZV doi: 10.18565/aig.2023.132

[12] Sukhikh GT, Serov VN, Adamyan LV, et al. Algorithms for the management of patients with endometriosis: an agreed position of experts from the Russian Society of Obstetricians and Gynecologists. Akusherstvo i Ginekologiya. 2023;(5):159–176. EDN: DTJOZV doi: 10.18565/aig.2023.132

[13] Glushich SYU, Lasachko SA, Rykov AA, et al. Review of recent data of etiopathogenesis and methods for diagnosing endometriosis (literature review). Medical and social problems of the family. 2020;25(4):54–68. EDN: IXQCRC

[14] Глушич С.Ю, Ласачко С.А, Рыков А.А, Железная А.А. Обзор последних данных этиопатогенеза и методов диагностики эндометриоза (обзор литературы) // Медико-социальные проблемы семьи. 2020. Т. 25, № 4. С. 54–68. EDN: IXQCRC

[15] Glushich SYU, Lasachko SA, Rykov AA, et al. Review of recent data of etiopathogenesis and methods for diagnosing endometriosis (literature review). Medical and social problems of the family. 2020;25(4):54–68. EDN: IXQCRC

[16] Taylor HS, Kotlyar AM, Flores VA. Endometriosis is a chronic systemic disease: clinical challenges and novel innovations. Lancet. 2021;397(10276):839–852. doi: 10.1016/S0140-6736(21)00389-5

[17] Taylor H.S, Kotlyar A.M, Flores V.A. Endometriosis is a chronic systemic disease: clinical challenges and novel innovations // Lancet. 2021. Vol. 397, N 10276. P. 839–852. doi: 10.1016/S0140-6736(21)00389-5

[18] Taylor HS, Kotlyar AM, Flores VA. Endometriosis is a chronic systemic disease: clinical challenges and novel innovations. Lancet. 2021;397(10276):839–852. doi: 10.1016/S0140-6736(21)00389-5

[19] Orazov MR, Radzinsky VE, Khamoshina MB, et al. Endometriosis-associated infertility: from myths to harsh reality. Difficult Patient. 2019;17(1-2):6–12. EDN: WAJZQN doi: 10.24411/2074-1995-2019-10001

[20] Оразов М.Р, Радзинский В.Е., Хамошина М.Б., и др. Бесплодие, ассоциированное с эндометриозом: от легенды к суровой реальности // Трудный пациент. 2019. Т. 17, № 1-2. С. 6–12. EDN: WAJZQN doi: 10.24411/2074-1995-2019-10001

[21] Orazov MR, Radzinsky VE, Khamoshina MB, et al. Endometriosis-associated infertility: from myths to harsh reality. Difficult Patient. 2019;17(1-2):6–12. EDN: WAJZQN doi: 10.24411/2074-1995-2019-10001

[22] Symons LK, Miller JE, Kay VR, et al. The immunopathophysiology of endometriosis. Trends Mol Med. 2018;24(9):748–762. doi: 10.1016/j.molmed.2018.07.004

[23] Symons L.K, Miller J.E, Kay V.R., et al. The immunopathophysiology of endometriosis // Trends Mol Med. 2018. Vol. 24, N 9. P. 748–762. doi: 10.1016/j.molmed.2018.07.004

[24] Symons LK, Miller JE, Kay VR, et al. The immunopathophysiology of endometriosis. Trends Mol Med. 2018;24(9):748–762. doi: 10.1016/j.molmed.2018.07.004

[25] de Fáveri C, Fermino PMP, Piovezan AP, Volpato LK. The inflammatory role of pro-resolving mediators in endometriosis: an integrative review // Int J Mol Sci. 2021;22(9):4370. doi: 10.3390/ijms22094370

[26] de Fáveri C., Fermino P.M.P., Piovezan A.P., Volpato L.K. The inflammatory role of pro-resolving mediators in endometriosis: an integrative review // Int J Mol Sci. 2021. Vol. 22, N 9. P. 4370. doi: 10.3390/ijms22094370

[27] de Fáveri C, Fermino PMP, Piovezan AP, Volpato LK. The inflammatory role of pro-resolving mediators in endometriosis: an integrative review // Int J Mol Sci. 2021;22(9):4370. doi: 10.3390/ijms22094370

[28] Ramírez-Pavez TN, Machado-Linde F, García-Peñarrubia P, et al. Optimization of peritoneal fluid and leukocyte collection in patients with endometriosis. Fertil Steril. 2023;120(4):917–919. doi: 10.1016/j.fertnstert.2023.06.030

[29] Ramírez-Pavez T.N., Machado-Linde F., García-Peñarrubia P., et al. Optimization of peritoneal fluid and leukocyte collection in patients with endometriosis // Fertil Steril. 2023. Vol. 120, N 4. P. 917–919. doi: 10.1016/j.fertnstert.2023.06.030

[30] Ramírez-Pavez TN, Machado-Linde F, García-Peñarrubia P, et al. Optimization of peritoneal fluid and leukocyte collection in patients with endometriosis. Fertil Steril. 2023;120(4):917–919. doi: 10.1016/j.fertnstert.2023.06.030

[31] Kudryavtseva EV, Geets AV, Mangileva YaA, et al. Modern non-invasive diagnosis of endometriosis. Ural Medical Journal. 2023;22(4):140–147. EDN: CONKMJ doi: 10.52420/2071-5943-2023-22-4-140-147

[32] Кудрявцева Е.В., Геец А.В., Мангилева Я.А., и др. Современные неинвазивные методы диагностики эндометриоза // Уральский медицинский журнал. 2023. Т. 22, № 4. С. 140–147. EDN: CONKMJ doi: 10.52420/2071-5943-2023-22-4-140-147

[33] Kudryavtseva EV, Geets AV, Mangileva YaA, et al. Modern non-invasive diagnosis of endometriosis. Ural Medical Journal. 2023;22(4):140–147. EDN: CONKMJ doi: 10.52420/2071-5943-2023-22-4-140-147

[34] Agarwal SK, Chapron C, Giudice LC, et al. Clinical diagnosis of endometriosis: a call to action. Am J Obstet Gynecol. 2019;220(4):354.e1–354.e12. doi: 10.1016/j.ajog.2018.12.039

[35] Agarwal S.K., Chapron C., Giudice L.C., et al. Clinical diagnosis of endometriosis: a call to action // Am J Obstet Gynecol. 2019. Vol. 220, N 4. P. 354.e1–354.e12. doi: 10.1016/j.ajog.2018.12.039

[36] Agarwal SK, Chapron C, Giudice LC, et al. Clinical diagnosis of endometriosis: a call to action. Am J Obstet Gynecol. 2019;220(4):354.e1–354.e12. doi: 10.1016/j.ajog.2018.12.039

[37] Wang XM, Ma ZY, Song N. Inflammatory cytokines IL-6, IL-10, IL-13, TNF-α and peritoneal fluid flora were associated with infertility in patients with endometriosis. Eur Rev Med Pharmacol Sci. 2018;22(9):2513–2518. doi: 10.26355/eurrev_201805_14899

[38] Wang X.-M., Ma Z.-Y., Song N. Inflammatory cytokines IL-6, IL-10, IL-13, TNF-α and peritoneal fluid flora were associated with infertility in patients with endometriosis // Eur Rev Med Pharmacol Sci. 2018. Vol. 22, N 9. P. 2513–2518. doi: 10.26355/eurrev_201805_14899

[39] Wang XM, Ma ZY, Song N. Inflammatory cytokines IL-6, IL-10, IL-13, TNF-α and peritoneal fluid flora were associated with infertility in patients with endometriosis. Eur Rev Med Pharmacol Sci. 2018;22(9):2513–2518. doi: 10.26355/eurrev_201805_14899

[40] Shields GS, Slavich GM, Perlman G, et al. The short-term reliability and long-term stability of salivary immune markers. Brain Behav Immun. 2019;81:650–654. doi: 10.1016/j.bbi.2019.06.007

[41] Shields G.S., Slavich G.M., Perlman G., et al. The short-term reliability and long-term stability of salivary immune markers // Brain Behav Immun. 2019. Vol. 81. P. 650–654. doi: 10.1016/j.bbi.2019.06.007

[42] Shields GS, Slavich GM, Perlman G, et al. The short-term reliability and long-term stability of salivary immune markers. Brain Behav Immun. 2019;81:650–654. doi: 10.1016/j.bbi.2019.06.007

[43] Monnaka VU, Hernandes C, Heller D, Podgaec S. Overview of miRNAs for the non-invasive diagnosis of endometriosis: evidence, challenges and strategies. A systematic review. Einstein (Sao Paulo). 2021;19:eRW5704. doi: 10.31744/einstein_journal/2021RW5704

[44] Monnaka V.U., Hernandes C., Heller D., Podgaec S. Overview of miRNAs for the non-invasive diagnosis of endometriosis: evidence, challenges and strategies. A systematic review // Einstein (Sao Paulo). 2021. Vol. 19. P. eRW5704. doi: 10.31744/einstein_journal/2021RW5704

[45] Monnaka VU, Hernandes C, Heller D, Podgaec S. Overview of miRNAs for the non-invasive diagnosis of endometriosis: evidence, challenges and strategies. A systematic review. Einstein (Sao Paulo). 2021;19:eRW5704. doi: 10.31744/einstein_journal/2021RW5704

[46] Smolarz B, Szyłło K, Romanowicz H. Endometriosis: epidemiology, classification, pathogenesis, treatment and genetics (review of literature). Int J Mol Sci. 2021;22(19):10554. doi: 10.3390/ijms221910554

[47] Smolarz B., Szyłło K., Romanowicz H. Endometriosis: epidemiology, classification, pathogenesis, treatment and genetics (review of literature) // Int J Mol Sci. 2021. Vol. 22, N 19. P. 10554. doi: 10.3390/ijms221910554

[48] Smolarz B, Szyłło K, Romanowicz H. Endometriosis: epidemiology, classification, pathogenesis, treatment and genetics (review of literature). Int J Mol Sci. 2021;22(19):10554. doi: 10.3390/ijms221910554

[49] Kondera-Anasz Z, Sikora J, Mielczarek-Palacz A, Jońca M. Concentrations of interleukin (IL)-1alpha, IL-1 soluble receptor type II (IL-1 sRII) and IL-1 receptor antagonist (IL-1 Ra) in the peritoneal fluid and serum of infertile women with endometriosis. Eur J Obstet Gynecol Reprod Biol. 2005;123(2):198–203. doi: 10.1016/j.ejogrb.2005.04.019

[50] Kondera-Anasz Z., Sikora J., Mielczarek-Palacz A., Jońca M. Concentrations of interleukin (IL)-1alpha, IL-1 soluble receptor type II (IL-1 sRII) and IL-1 receptor antagonist (IL-1 Ra) in the peritoneal fluid and serum of infertile women with endometriosis // Eur J Obstet Gynecol Reprod Biol. 2005. Vol. 123, N 2. P. 198–203. doi: 10.1016/j.ejogrb.2005.04.019

[51] Kondera-Anasz Z, Sikora J, Mielczarek-Palacz A, Jońca M. Concentrations of interleukin (IL)-1alpha, IL-1 soluble receptor type II (IL-1 sRII) and IL-1 receptor antagonist (IL-1 Ra) in the peritoneal fluid and serum of infertile women with endometriosis. Eur J Obstet Gynecol Reprod Biol. 2005;123(2):198–203. doi: 10.1016/j.ejogrb.2005.04.019

[52] Incognito GG, Di Guardo F, Gulino FA, et al. Interleukin-6 as a useful predictor of endometriosis-associated infertility: a systematic review. Int J Fertil Steril. 2023;17(4):226–230. doi: 10.22074/ijfs.2023.557683.1329

[53] Incognito G.G., Di Guardo F., Gulino F.A., et al. Interleukin-6 as a useful predictor of endometriosis-associated infertility: a systematic review // Int J Fertil Steril. 2023. Vol. 17, N 4. P. 226–230. doi: 10.22074/ijfs.2023.557683.1329

[54] Incognito GG, Di Guardo F, Gulino FA, et al. Interleukin-6 as a useful predictor of endometriosis-associated infertility: a systematic review. Int J Fertil Steril. 2023;17(4):226–230. doi: 10.22074/ijfs.2023.557683.1329

[55] Bulun SE, Yilmaz BD, Sison C, et al. Endometriosis. Endocr Rev. 2019;40(4):1048–1079. doi: 10.1210/er.2018-00242

[56] Bulun S.E., Yilmaz B.D., Sison C., et al. Endometriosis // Endocr Rev. 2019. Vol. 40, N 4. P. 1048–79. doi: 10.1210/er.2018-00242

[57] Bulun SE, Yilmaz BD, Sison C, et al. Endometriosis. Endocr Rev. 2019;40(4):1048–1079. doi: 10.1210/er.2018-00242

[58] Allaire C, Bedaiwy MA, Yong PJ. Diagnosis and management of endometriosis. CMAJ. 2023;195(10):E363–E371. doi: 10.1503/cmaj.220637

[59] Allaire C., Bedaiwy M.A., Yong P.J. Diagnosis and management of endometriosis // CMAJ. 2023. Vol. 195, N 10. P. E363–Е371. doi: 10.1503/cmaj.220637

[60] Allaire C, Bedaiwy MA, Yong PJ. Diagnosis and management of endometriosis. CMAJ. 2023;195(10):E363–E371. doi: 10.1503/cmaj.220637

[61] Horne AW, Missmer SA. Pathophysiology, diagnosis, and management of endometriosis. BMJ. 2022;379:e070750. doi: 10.1136/bmj-2022-070750

[62] Horne A.W., Missmer S.A. Pathophysiology, diagnosis, and management of endometriosis // BMJ. 2022. Vol. 379. doi: 10.1136/bmj-2022-070750

[63] Horne AW, Missmer SA. Pathophysiology, diagnosis, and management of endometriosis. BMJ. 2022;379:e070750. doi: 10.1136/bmj-2022-070750

[64] Nisenblat V, Bossuyt PM, Shaikh R, et al. Blood biomarkers for the non-invasive diagnosis of endometriosis. Cochrane Database Syst Rev. 2016;2016(5):CD012179. doi: 10.1002/14651858.CD012179

[65] Nisenblat V., Bossuyt P.M.M., Shaikh R., et al. Blood biomarkers for the non-invasive diagnosis of endometriosis // Cochrane Database Syst Rev. 2016. Vol. 2016, N 5. P. CD012179. doi: 10.1002/14651858.CD012179

[66] Nisenblat V, Bossuyt PM, Shaikh R, et al. Blood biomarkers for the non-invasive diagnosis of endometriosis. Cochrane Database Syst Rev. 2016;2016(5):CD012179. doi: 10.1002/14651858.CD012179

[67] Nam Y, Kim YY, Chang JY, Kho HS. Salivary biomarkers of inflammation and oxidative stress in healthy adults. Arch Oral Biol. 2019;97:215–222. doi: 10.1016/j.archoralbio.2018.10.026

[68] Nam Y., Kim Y.-Y., Chang J.-Y., Kho H.-S. Salivary biomarkers of inflammation and oxidative stress in healthy adults // Arch Oral Biol. 2019. Vol. 97. P. 215–22. doi: 10.1016/j.archoralbio.2018.10.026

[69] Nam Y, Kim YY, Chang JY, Kho HS. Salivary biomarkers of inflammation and oxidative stress in healthy adults. Arch Oral Biol. 2019;97:215–222. doi: 10.1016/j.archoralbio.2018.10.026

[70] Szabo YZ, Slavish DC. Measuring salivary markers of inflammation in health research: A review of methodological considerations and best practices. Psychoneuroendocrinology. 2021;124:105069. doi: 10.1016/j.psyneuen.2020.105069

[71] Szabo Y.Z., Slavish D.C. Measuring salivary markers of inflammation in health research: A review of methodological considerations and best practices // Psychoneuroendocrinology. 2021. Vol. 124. doi: 10.1016/j.psyneuen.2020.105069

[72] Szabo YZ, Slavish DC. Measuring salivary markers of inflammation in health research: A review of methodological considerations and best practices. Psychoneuroendocrinology. 2021;124:105069. doi: 10.1016/j.psyneuen.2020.105069

RIGHTS & PERMISSIONS

Eco-Vector